 Claudia Crocini
Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 15 | 2024 | 499 | 2.960 |
Why?
| | Optogenetics | 4 | 2024 | 112 | 1.300 |
Why?
| | Cardiomyopathy, Hypertrophic | 5 | 2022 | 132 | 1.220 |
Why?
| | Action Potentials | 9 | 2024 | 486 | 1.020 |
Why?
| | Myocardial Contraction | 6 | 2017 | 335 | 1.000 |
Why?
| | Heart | 4 | 2020 | 637 | 0.970 |
Why?
| | Boidae | 1 | 2024 | 20 | 0.890 |
Why?
| | Cardiomegaly | 1 | 2024 | 172 | 0.830 |
Why?
| | Calcium Signaling | 6 | 2017 | 250 | 0.820 |
Why?
| | Heart Failure | 4 | 2023 | 2150 | 0.720 |
Why?
| | Myofibrils | 2 | 2024 | 49 | 0.720 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 613 | 0.650 |
Why?
| | Sarcolemma | 5 | 2024 | 40 | 0.650 |
Why?
| | Calcium | 4 | 2024 | 1213 | 0.610 |
Why?
| | Excitation Contraction Coupling | 4 | 2017 | 17 | 0.600 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 84 | 0.600 |
Why?
| | Arrhythmias, Cardiac | 3 | 2018 | 317 | 0.580 |
Why?
| | Channelrhodopsins | 1 | 2016 | 16 | 0.530 |
Why?
| | Electric Countershock | 1 | 2016 | 105 | 0.510 |
Why?
| | Adrenergic beta-Agonists | 1 | 2016 | 132 | 0.500 |
Why?
| | Biocompatible Materials | 1 | 2019 | 395 | 0.480 |
Why?
| | Muscle Proteins | 2 | 2013 | 220 | 0.450 |
Why?
| | Muscle Cells | 1 | 2014 | 42 | 0.450 |
Why?
| | Light | 1 | 2017 | 360 | 0.450 |
Why?
| | Heart Diseases | 2 | 2017 | 350 | 0.440 |
Why?
| | Animals | 23 | 2024 | 35361 | 0.390 |
Why?
| | Hydrogels | 1 | 2019 | 638 | 0.390 |
Why?
| | Myocardium | 6 | 2024 | 980 | 0.380 |
Why?
| | Heart Ventricles | 4 | 2018 | 781 | 0.370 |
Why?
| | Cardiomyopathy, Dilated | 3 | 2022 | 381 | 0.360 |
Why?
| | Repressor Proteins | 1 | 2013 | 406 | 0.330 |
Why?
| | Mutation | 6 | 2022 | 3717 | 0.310 |
Why?
| | Tissue Engineering | 1 | 2013 | 396 | 0.310 |
Why?
| | Cardiomyopathies | 2 | 2023 | 340 | 0.300 |
Why?
| | Heart Atria | 2 | 2020 | 128 | 0.300 |
Why?
| | Nuclear Proteins | 1 | 2013 | 663 | 0.290 |
Why?
| | Intracellular Space | 2 | 2019 | 69 | 0.290 |
Why?
| | Cells, Cultured | 5 | 2017 | 4083 | 0.240 |
Why?
| | Rats | 5 | 2020 | 5500 | 0.230 |
Why?
| | Rats, Wistar | 2 | 2016 | 441 | 0.220 |
Why?
| | Postprandial Period | 1 | 2024 | 104 | 0.220 |
Why?
| | Hypertrophy, Left Ventricular | 2 | 2022 | 126 | 0.210 |
Why?
| | Gonadal Steroid Hormones | 1 | 2024 | 131 | 0.210 |
Why?
| | Green Fluorescent Proteins | 2 | 2014 | 385 | 0.190 |
Why?
| | Mice | 9 | 2022 | 16937 | 0.190 |
Why?
| | Phenotype | 4 | 2019 | 3076 | 0.180 |
Why?
| | Rats, Inbred SHR | 1 | 2020 | 44 | 0.180 |
Why?
| | Disease Models, Animal | 5 | 2020 | 4063 | 0.170 |
Why?
| | Sex Characteristics | 2 | 2024 | 737 | 0.170 |
Why?
| | Adaptation, Physiological | 1 | 2024 | 513 | 0.170 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2021 | 101 | 0.170 |
Why?
| | Capillaries | 1 | 2020 | 103 | 0.170 |
Why?
| | Dilatation | 1 | 2020 | 60 | 0.160 |
Why?
| | Capsules | 1 | 2019 | 40 | 0.160 |
Why?
| | Optical Imaging | 2 | 2018 | 56 | 0.160 |
Why?
| | Troponin T | 2 | 2017 | 57 | 0.160 |
Why?
| | Coronary Vessels | 1 | 2020 | 241 | 0.150 |
Why?
| | Cellular Microenvironment | 1 | 2019 | 81 | 0.150 |
Why?
| | Energy Metabolism | 1 | 2024 | 874 | 0.150 |
Why?
| | Sarcoplasmic Reticulum | 2 | 2017 | 45 | 0.150 |
Why?
| | Myosin Heavy Chains | 1 | 2019 | 170 | 0.150 |
Why?
| | Microscopy, Confocal | 2 | 2017 | 310 | 0.150 |
Why?
| | Atrioventricular Block | 1 | 2018 | 35 | 0.150 |
Why?
| | Protein Transport | 1 | 2019 | 428 | 0.140 |
Why?
| | Electric Stimulation Therapy | 1 | 2018 | 77 | 0.140 |
Why?
| | Cell Surface Extensions | 1 | 2017 | 13 | 0.140 |
Why?
| | Ranolazine | 1 | 2017 | 25 | 0.140 |
Why?
| | Sodium Channel Blockers | 1 | 2017 | 24 | 0.140 |
Why?
| | Gastrointestinal Microbiome | 1 | 2024 | 641 | 0.130 |
Why?
| | Extracellular Space | 1 | 2017 | 120 | 0.130 |
Why?
| | Diet | 1 | 2024 | 1213 | 0.130 |
Why?
| | Heart Conduction System | 1 | 2017 | 95 | 0.130 |
Why?
| | Sodium | 1 | 2017 | 206 | 0.130 |
Why?
| | Fibroblasts | 1 | 2021 | 948 | 0.130 |
Why?
| | Cell Survival | 1 | 2019 | 1086 | 0.120 |
Why?
| | Ion Transport | 1 | 2015 | 62 | 0.120 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2016 | 127 | 0.120 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2013 | 148 | 0.120 |
Why?
| | Atrial Fibrillation | 1 | 2020 | 376 | 0.120 |
Why?
| | Actin Cytoskeleton | 1 | 2015 | 104 | 0.120 |
Why?
| | Equipment Design | 1 | 2016 | 514 | 0.120 |
Why?
| | Humans | 13 | 2024 | 129650 | 0.110 |
Why?
| | Polyethylene Glycols | 1 | 2019 | 601 | 0.110 |
Why?
| | Proteasome Inhibitors | 1 | 2013 | 42 | 0.100 |
Why?
| | Haploinsufficiency | 1 | 2013 | 48 | 0.100 |
Why?
| | Lamin Type A | 1 | 2013 | 48 | 0.100 |
Why?
| | Transduction, Genetic | 1 | 2013 | 128 | 0.100 |
Why?
| | Dependovirus | 1 | 2013 | 62 | 0.100 |
Why?
| | LIM Domain Proteins | 1 | 2012 | 17 | 0.100 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 376 | 0.100 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 2004 | 0.100 |
Why?
| | Heterozygote | 1 | 2013 | 272 | 0.100 |
Why?
| | Mice, Transgenic | 4 | 2019 | 2119 | 0.090 |
Why?
| | Genetic Vectors | 1 | 2013 | 312 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2019 | 2391 | 0.090 |
Why?
| | Oligopeptides | 1 | 2013 | 257 | 0.090 |
Why?
| | Transfection | 1 | 2013 | 911 | 0.090 |
Why?
| | Male | 10 | 2024 | 63681 | 0.090 |
Why?
| | Animals, Newborn | 1 | 2013 | 835 | 0.090 |
Why?
| | Gene Expression | 1 | 2015 | 1472 | 0.090 |
Why?
| | Membrane Potentials | 2 | 2024 | 293 | 0.080 |
Why?
| | Models, Biological | 1 | 2017 | 1722 | 0.080 |
Why?
| | Rats, Inbred WKY | 2 | 2020 | 35 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 442 | 0.080 |
Why?
| | Mice, Knockout | 1 | 2015 | 2871 | 0.080 |
Why?
| | Genotype | 1 | 2013 | 1839 | 0.070 |
Why?
| | Sex Factors | 2 | 2024 | 1968 | 0.070 |
Why?
| | Aging | 1 | 2017 | 1776 | 0.070 |
Why?
| | Time Factors | 2 | 2017 | 6556 | 0.070 |
Why?
| | Mice, Inbred C57BL | 4 | 2019 | 5440 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2548 | 0.050 |
Why?
| | Sarcomeres | 1 | 2022 | 92 | 0.050 |
Why?
| | Isoproterenol | 1 | 2022 | 115 | 0.050 |
Why?
| | Angiotensin II | 1 | 2022 | 95 | 0.050 |
Why?
| | Myosins | 1 | 2022 | 133 | 0.050 |
Why?
| | Alternative Splicing | 1 | 2023 | 218 | 0.040 |
Why?
| | Cell Membrane | 1 | 2024 | 732 | 0.040 |
Why?
| | Myofibroblasts | 1 | 2021 | 121 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2020 | 54 | 0.040 |
Why?
| | Swine | 1 | 2021 | 760 | 0.040 |
Why?
| | Vascular Remodeling | 1 | 2020 | 192 | 0.040 |
Why?
| | Electrophysiologic Techniques, Cardiac | 1 | 2018 | 79 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 333 | 0.040 |
Why?
| | Fluorescence Recovery After Photobleaching | 1 | 2017 | 19 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2021 | 504 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 531 | 0.030 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2017 | 181 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2017 | 108 | 0.030 |
Why?
| | Proteomics | 1 | 2023 | 1062 | 0.030 |
Why?
| | Hemodynamics | 1 | 2020 | 1090 | 0.030 |
Why?
| | Blotting, Western | 1 | 2017 | 1205 | 0.030 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2017 | 385 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2017 | 547 | 0.030 |
Why?
| | Ventricular Function, Left | 1 | 2017 | 527 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2021 | 1902 | 0.030 |
Why?
| | Ubiquitin | 1 | 2013 | 64 | 0.030 |
Why?
| | Female | 4 | 2024 | 68776 | 0.030 |
Why?
| | Heart Rate | 1 | 2017 | 802 | 0.030 |
Why?
| | Proteolysis | 1 | 2013 | 166 | 0.020 |
Why?
| | Models, Cardiovascular | 1 | 2013 | 191 | 0.020 |
Why?
| | Pedigree | 1 | 2012 | 487 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2013 | 582 | 0.020 |
Why?
| | Signal Transduction | 1 | 2022 | 4925 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2282 | 0.020 |
Why?
| | Disease Progression | 1 | 2013 | 2635 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2017 | 3408 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2012 | 3381 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1614 | 0.010 |
Why?
| | Young Adult | 1 | 2012 | 12426 | 0.010 |
Why?
| | Adolescent | 1 | 2012 | 20393 | 0.010 |
Why?
| | Aged | 1 | 2012 | 22103 | 0.010 |
Why?
| | Child | 1 | 2012 | 20883 | 0.010 |
Why?
| | Middle Aged | 1 | 2012 | 31154 | 0.010 |
Why?
| | Adult | 1 | 2012 | 35576 | 0.010 |
Why?
|
|
Crocini's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|